Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30051244HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051245HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051246HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051247HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051248HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051249HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051250HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051251HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051252HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TVIS30051253HIVENSG00000169967.17protein_codingMAP3K2NoNo10746Q9Y2U5
TCGA Plot Options
Drug Information
GeneMAP3K2
DrugBank IDDB06616
Drug NameBosutinib
Target IDBE0004745
UniProt IDQ9Y2U5
Regulation Typeinhibitor
PubMed IDs23134735
CitationsAhmad S, Hughes MA, Johnson GL, Scott JE: Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors. J Biomol Screen. 2013 Apr;18(4):388-99. doi: 10.1177/1087057112466430. Epub 2012 Nov 7.
GroupsApproved
Direct Classification4-aminoquinolines
SMILESCOC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
PathwaysBosutinib Inhibition of BCR-ABL
PharmGKB
ChEMBLCHEMBL288441